Vaxxinity(VAXX) - 2022 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | FORM 10-Q | | --- | | (Mark One) | | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | For the quarterly period ended June 30, 2022 | | -OR- | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 | | For the transition period from _________ to _________ | | Commission file number 001-41058 | | Vaxxinity, Inc. | | (Exact name of registrant as specified i ...